PharmaShots Weekly Snapshots (November 28 – December 02, 2022)
Published: Dec 02, 2022 | Tags: Compass Therapeutics, CTX-471, Keytruda, pembrolizumab, Advanced Solid Tumors, Clinical Trial
Published: Dec 02, 2022 | Tags: Qilu Pharmaceutical, QL1706, Non-Small Cell Lung Cancer, Clinical Trial, P-II Study, ESMO, 2022
Published: Dec 02, 2022 | Tags: Rigel, Rezlidhia, olutasidenib, Acute Myeloid Leukemia, IDH1 Mutation, Regulatory, US, FDA, Approval
Published: Dec 02, 2022 | Tags: UroGen, Jelmyto, mitomycin, Low-Grade Upper Tract Urothelial Cancer, Clinical Trial, P-III (OLYMPUS) Trial, SUO, 2022
Published: Dec 02, 2022 | Tags: Anavex, ANAVEX 2–73, blarcamesine, Early Alzheimer’s Disease, Clinical Trial, P-IIb/III (ANAVEX 2-73-AD-004) Trial, CTAD, 2022
Published: Dec 02, 2022 | Tags: SCYNEXIS, Brexafemme, ibrexafungerp, Vulvovaginal Candidiasis, Regulatory, US, FDA, Approval
Published: Dec 01, 2022 | Tags: AbCellera, Rallybio, Antibody-Based Therapies, Rare Diseases, Ab discovery engine, Pharma
Published: Dec 01, 2022 | Tags: IPA, BioStrand, BriaCell, Anti-Cancer Antibodies, LENSai software, HYFT Universal Fingerprint technologies
Published: Dec 01, 2022 | Tags: Liminatus Pharma, Iris, colorectal, pancreatic, gastric, esophageal cancers, M&A
Published: Dec 01, 2022 | Tags: Regeneron, Evkeeza, evinacumab, Homozygous Familial Hypercholesterolemia, Regulatory, US, FDA, Acceptance, sBLA, Priority Review
Published: Dec 01, 2022 | Tags: BioNTech, Ryvu Therapeutics, Immuno-Modulatory Small Molecule Candidates, oncology, Pharma
Published: Dec 01, 2022 | Tags: Eli Lilly, Donanemab, Early Symptomatic Alzheimer's Disease, Clinical Trial, P-III, TRAILBLAZER-ALZ 4 Study
Published: Nov 30, 2022 | Tags: Eisai, Biogen, Lecanemab, Early Alzheimer's Disease, Clinical Trial, P-III, New England Journal of Medicine, Clarity AD
Published: Nov 30, 2022 | Tags: Shanghai Henlius Biotech, Hansizhuang, serplulimab, Extensive-Stage Small Cell Lung Cancer Treatment, MSI-H solid tumors, squamous non-small cell lung cancer, Clinical Trial, NMPA, US FDA, NDA
Published: Nov 30, 2022 | Tags: Turnstone Biologics, National Cancer Institute, TIL Therapy, Immunotherapy, Solid Tumors, Pharma
Autobahn Initiates the P-I Trial of ABX-002 for the Treatment of Major Depressive Disorder
Published: Nov 30, 2022 | Tags: Autobahn, ABX-002, Major Depressive Disorder, Clinical Trial, P-I
Published: Nov 30, 2022 | Tags: Aclaris, Pediatrix, ATI-1777, Atopic Dermatitis, Clinical Trials, Greater China
Published: Nov 30, 2022 | Tags: Immutep, Merck KGaA, Pfizer, Eftilagimod Alpha, Avelumab, Urothelial Cancer, Clinical Trial, Germany, INSIGHT-005, INSIGHT-004
Published: Nov 29, 2022 | Tags: CSL Vifor, Fresenius Kabi, Ferinject, Iron Deficiency, Regulatory, NMPA Approval
AstraZeneca to Acquire Neogene Therapeutics for ~$320M
Published: Nov 29, 2022 | Tags: AstraZeneca, Neogene Therapeutics, Acquire, ~$320M, solid tumors
Published: Nov 29, 2022 | Tags: Full-Life Technologies, Focus-X Therapeutics, Peptide-Focused Radiopharmaceutical Pipeline, pancreatic cancer, metastatic castration resistant prostate cancer, M&A
Published: Nov 29, 2022 | Tags: axsome Therapeutics, AXS-05, Alzheimer’s Disease Agitation, Clinical Trial, P-III, ACCORD Trial
Arcutis Reports P-IIb Study Results of Roflumilast for the Treatment of Plaque Psoriasis
Published: Nov 29, 2022 | Tags: Arcutis, Roflumilast Cream, Plaque Psoriasis, Clinical Trial, P-IIb Study
Published: Nov 29, 2022 | Tags: Biocytogen, ADC Therapeutics, Antibody-Based Therapies, Project Integrum, RenMice HiTS Platform, Option Agreement, Biotech
Published: Nov 28, 2022 | Tags: RadNet, Aidence, Google Health, Lung Cancer, AI Solutions, NELSON trial, Pharma
Published: Nov 28, 2022 | Tags: AstraZeneca, C4XD, NRF2 Activator Program, Pharma
GSK Submits Respiratory Syncytial Virus Vaccine for Regulatory Review to Health Canada
Published: Nov 28, 2022 | Tags: GSK, Respiratory Syncytial Virus Vaccine, Regulatory Review, Health Canada, Clinical Trial
Published: Nov 28, 2022 | Tags: Edwards, EVOQUE Transfemoral Transcatheter Tricuspid Valve Replacement, Tricuspid Regurgitation, Clinical Trial, TRISCEND Study
Published: Nov 28, 2022 | Tags: Lyvgen, BMS, LVGN7409, Nivolumab, Non-Small Cell Lung Cancer, Pharma
Published: Nov 28, 2022 | Tags: BMS, Opdivo, nivolumab, Gastroesophageal Cancers, Regulatory, NICE
Related Post: PharmaShots Weekly Snapshots (November 21 - 25, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.